Min Ji Selected Research

1- (methanesulfonamido- 1- naphthyloxy)- 2- (N- (4- methane sulfonamidophenethyl)-N-acetamido)ethane

4/2007

Calcium antagonist property of CPU228, a dofetilide derivative, contributes to its low incidence of torsades de pointes in rabbits.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Ji Research Topics

Disease

38	Neoplasms (Cancer) 06/2022 - 09/2003
8	Leukemia 01/2021 - 03/2008
8	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 01/2012
6	Neoplasm Metastasis (Metastasis) 06/2022 - 09/2012
5	Shock 10/2022 - 01/2016
5	Hemorrhage 11/2019 - 09/2003
4	Cataract (Cataracts) 04/2022 - 01/2019
4	Breast Neoplasms (Breast Cancer) 09/2021 - 12/2013
4	Ocular Hypertension (Glaucoma, Suspect) 11/2019 - 09/2012
4	Gliosis 01/2018 - 09/2012
3	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2018 - 01/2012
3	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 01/2007
2	Pathologic Processes 10/2022 - 05/2016
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/2022 - 08/2019
2	Substance-Related Disorders (Drug Abuse) 01/2022 - 01/2021
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 04/2021 - 01/2020
2	Hyperthermia 06/2020 - 01/2020
2	Adenocarcinoma of Lung 01/2020 - 02/2015
2	Astigmatism 01/2020 - 01/2019
2	Carcinogenesis 01/2020 - 02/2009
2	Inflammation (Inflammations) 01/2019 - 01/2015
2	Colonic Neoplasms (Colon Cancer) 01/2019 - 08/2015
2	Hyperlipidemias (Hyperlipidemia) 04/2018 - 07/2015
2	Glioma (Gliomas) 01/2018 - 11/2017
2	Hypoxia (Hypoxemia) 01/2016 - 11/2006
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2015 - 01/2012
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 09/2014 - 06/2011
2	Starvation 09/2014 - 11/2008
1	Drug-Related Side Effects and Adverse Reactions 06/2022
1	Parkinson Disease (Parkinson's Disease) 06/2022
1	Dyskinesias (Dyskinesia) 06/2022
1	AIDS-Related Complex (ARC) 01/2022
1	Vision Disorders (Hemeralopia) 01/2022
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022
1	Macular Edema 01/2022
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2022
1	Epiretinal Membrane (Epiretinal Membranes) 01/2022
1	Glucocorticoid Receptor Deficiency 01/2022

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2022 - 11/2004
8	Pharmaceutical PreparationsIBA 11/2021 - 07/2014
6	Retinaldehyde (Retinal)IBA 01/2022 - 09/2012
6	Biological ProductsIBA 11/2021 - 06/2014
5	CytokinesIBA 01/2022 - 01/2012
4	GossypolIBA 08/2015 - 11/2004
3	Fluorescent Dyes (Fluorescent Probes)IBA 10/2022 - 04/2017
3	LigandsIBA 01/2022 - 04/2017
3	Interleukin-10 (Interleukin 10)IBA 04/2021 - 05/2012
3	EnzymesIBA 10/2020 - 05/2012
3	ProdrugsIBA 01/2020 - 03/2014
3	AntigensIBA 01/2020 - 03/2008
3	Liposomes (Liposome)IBA 01/2020 - 01/2019
3	Biomarkers (Surrogate Marker)IBA 08/2019 - 06/2011
3	Glial Fibrillary Acidic ProteinIBA 01/2018 - 09/2012
2	Peptides (Polypeptides)IBA 01/2022 - 09/2005
2	Naloxone (Narcan)FDA LinkGeneric 01/2022 - 01/2021
2	Morphine (MS Contin)FDA LinkGeneric 01/2022 - 01/2021
2	Dopamine D3 ReceptorsIBA 01/2022 - 01/2021
2	chromium hexavalent ionIBA 10/2021 - 01/2021
2	InterleukinsIBA 01/2021 - 05/2012
2	Heavy MetalsIBA 01/2021 - 01/2016
2	Hormones (Hormone)IBA 01/2021 - 07/2008
2	Ferrosoferric Oxide (Magnetite)FDA Link 06/2020 - 04/2018
2	AcidsIBA 01/2020 - 11/2018
2	RNA-Binding Proteins (RNA-Binding Protein)IBA 01/2020 - 08/2015
2	Irinotecan (Camptosar)FDA LinkGeneric 01/2020 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2020 - 11/2018
2	Imatinib Mesylate (Gleevec)FDA Link 01/2018 - 02/2016
2	WastewaterIBA 01/2017 - 11/2008
2	Chemokine ReceptorsIBA 01/2017 - 01/2015
2	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2016 - 01/2016
2	3,4-dihydroxyphenylglycolIBA 12/2016 - 01/2016
2	MicroRNAs (MicroRNA)IBA 05/2016 - 02/2009
2	ImmunosorbentsIBA 01/2015 - 05/2012
2	Dasatinib (BMS 354825)FDA Link 05/2013 - 01/2012
2	Gefitinib (Iressa)FDA Link 12/2011 - 06/2010
1	NitrogenIBA 10/2022
1	Cysteine (L-Cysteine)FDA Link 10/2022
1	Levodopa (L Dopa)FDA LinkGeneric 06/2022
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2022
1	anlotinibIBA 06/2022
1	Immune Checkpoint InhibitorsIBA 06/2022
1	GlucocorticoidsIBA 01/2022
1	LecithinsIBA 01/2022
1	Amyloid Precursor Protein Secretases (beta-Secretase)IBA 01/2022
1	Gamma Secretase Inhibitors and ModulatorsIBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	benzothiopheneIBA 01/2022
1	Dopamine Receptors (Dopamine Receptor)IBA 01/2022
1	morpholineIBA 01/2022
1	Opioid Analgesics (Opioids)IBA 01/2022
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2022
1	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 11/2021

Therapy/Procedure

11	Therapeutics 11/2021 - 09/2003
8	Drug Therapy (Chemotherapy) 09/2021 - 11/2004
3	Radiotherapy 06/2022 - 03/2016
3	Intravitreal Injections 01/2018 - 01/2016
2	Stents 01/2021 - 11/2019
2	Lasers (Laser) 01/2020 - 01/2020
1	Photothermal Therapy 05/2022
1	Optical Devices 04/2022